IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$10.03
-6.70% today
Updated 2026-04-29
Market cap
$135.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.20
Dividend yield
—
52W range
$5 – $15
Volume
2.8M
Immunic Inc (IMUX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |